KEYNOTE PRESENTATIONS:

Repurposing of Enbrel for Alzheimer’s Disease
Edward Tobinick, M.D., Assistant Clinical Professor of Medicine at the University of California, Los Angeles and Director of the Institute for Neurological Research

The Indications Discovery Unit at Pfizer: First Year Check Up
Donald E. Frail, Ph.D., Head, Indicati ons Discovery Unit, Pfi zer Global Research and Development

Scientific Advisory Board

Thomas Barnes, Ph.D., Senior Vice President, Drug Repositioning Discovery, Ore Pharmaceuticals Inc.
Stephen Donahue, M.D., Senior Vice President, Clinical Development, Ore Pharmaceuticals Inc.
Christopher A. Lipinski, Ph.D., Scientific Advisor, Melior Discovery
Marcel van Duin, Ph.D., Executive Director & Head, Department of Pharmacology, NV Organon, a part of Schering-Plough Corporation

Co-located Event:

Accelerating Proof-of-Concept

October 8, 2008  |  Boston, Massachusetts
Click here for updated conference information

Discounted Joint Pricing Options Available!